ID: ALA5083714

Max Phase: Preclinical

Molecular Formula: C40H57N5O11S

Molecular Weight: 815.99

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1C(=O)O[C@@H]2C[C@@]3(C)[C@H](OC(=O)CCCc4cn(CCOCCOCCOCCNC(=O)CCCC[C@H]5SC[C@H]6C(=O)NC(=O)[C@@H]56)nn4)CC[C@H](C)[C@@]34O[C@H]4[C@H]12

Standard InChI:  InChI=1S/C40H57N5O11S/c1-24-11-12-30(39(3)21-28-33(25(2)38(50)54-28)35-40(24,39)56-35)55-32(47)10-6-7-26-22-45(44-43-26)14-16-52-18-20-53-19-17-51-15-13-41-31(46)9-5-4-8-29-34-27(23-57-29)36(48)42-37(34)49/h22,24,27-30,33-35H,2,4-21,23H2,1,3H3,(H,41,46)(H,42,48,49)/t24-,27+,28+,29+,30+,33+,34+,35-,39-,40-/m0/s1

Standard InChI Key:  NXCQNAGTRUJJJJ-KIXWVXSCSA-N

Associated Targets(Human)

Annexin A2 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

4T1 1737 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 815.99Molecular Weight (Monoisotopic): 815.3775AlogP: 2.32#Rotatable Bonds: 22
Polar Surface Area: 198.80Molecular Species: NEUTRALHBA: 15HBD: 2
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.10CX Basic pKa: 0.30CX LogP: 2.14CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 57QED Weighted: 0.06Np Likeness Score: 0.56

References

1. Wei M, Zhou Y, Li C, Yang Y, Liu T, Liu Y, Wei Y, Liu N, Liu S, Wang Q, Cao S, Sun Y, Sheng P, Lu C, Yang C, Liu X, Yang G..  (2021)  5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2.,  64  (17.0): [PMID:34351142] [10.1021/acs.jmedchem.1c00267]

Source